This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, provides $221,120.00 to the University of Texas Health Science Center at Houston (UTHealth) to conduct research on improving neural progenitor cell survival and migration in the context of neurodegenerative diseases and brain injuries, such as stroke. The research investigates the potential of adult central nervous system endothelial cells to express developmental genes following epigenetic reprogramming, with the goal of guiding neural progenitor cell migration and enhancing neurovascular communication. The anticipated outcomes seek to contribute fundamental knowledge and potentially transform neural progenitor cell treatment strategies by combining vascular rejuvenation with neural progenitor cell transplantation to improve cognitive, motor, and overall clinical outcomes. The award period runs from Sep 1, 2024 to Aug 31, 2026.
Mod # | Description | Reason For Modification | Federal Obligation (Click to sort descending) | Date (Click to sort ascending) |
|---|---|---|---|---|
| Not listed | $221.1k | 8/30/24 |